Results 181 to 181 of about 5,596 (181)
Some of the next articles are maybe not open access.
Reviewer #3 (Public review): The Mac1 ADP-ribosylhydrolase is a therapeutic target for SARS-CoV-2
openaire +1 more source
Reviewer #3 (Public review): The Mac1 ADP-ribosylhydrolase is a therapeutic target for SARS-CoV-2
openaire +1 more source